Search Results

Containing any of the words

Only of the type

A randomized, double-blind, placebo-controlled, parallel-group, multicenter, event-driven Phase III study to investigate the efficacy and safety of finerenone, in addition to standard of care, on the progression of kidney disease in subjects with type 2 diabetes mellitus and the clinical diagnosis of diabetic kidney disease Drug Clinical Trial

A randomized, double-blind, placebo-controlled, parallel-group, multicenter, event-driven Phase III study to investigate the efficacy and safety of finerenone on the reduction of cardiovascular morbidity and mortality in subjects with type 2 diabetes mellitus and the clinical diagnosis of diabetic kidney disease in addition to standard of care(FIGARO -DKD) Drug Clinical Trial

Unmet needs in allergic rhinitis: International Survey on Mangment of Allergic Rhinitis by Physician and Patient. Drug Clinical Trial

Registry in the management of Acute Diarrhea in Children : Observational study in Daily practice Drug Clinical Trial

Superiority of Insulin Glargine Lantus vs. NPH: Treat to Normoglycemia Concept.Effect of Insulin Glargine in Comparison to Insulin NPH in Insulin-nave People With Type 2 Diabetes Mellitus Treated With at Least One OAD and Not Adequately Controlled Drug Clinical Trial

Disease pattern in patient with acute respiratory tract infections in Saudi Arabia Drug Clinical Trial

National, observational, cross sectional survey evaluating the atrial fibrillation management and cardiovascular risk profile of AF patient. Drug Clinical Trial

An international, multicenter, observational study to compare real life VTE prophylaxis, during hospital stay, in cancer patients undergoing major abdominal or pelvic surgery versus international guidelines (ACCP 2008). Drug Clinical Trial

Registry on Monitoring the Effectiveness and Tolerability of Basal (Plus/Bolus) Regimen with LantusÒ (Insulin Glargine) and ApidraÒ (Insulin Glulisine) in T2 Diabetes Mellitus Patients in Everyday Practice in Saudi Drug Clinical Trial

Inhibitor Development in Previously Untreated Patients (PUPs) or Minimally Blood Component-Treated Patients (MBCTPs) When Exposed to Plasma-derived Von Willebrand Factor-Containing Factor VIII (VWF/FVIII) Concentrates and to Recombinant Factor VIII (rFVIII) Concentrates: An Independent, International, Multicentre, Prospective, Controlled, Randomised, Open Label, Clinical Trial) Drug Clinical Trial